Although interactions between amyloid-beta and tau proteins have been implicated in Alzheimer’s disease (AD), the precise mechanisms by which these interactions contribute to disease progression are not yet fully understood. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.